Document Detail


The safety of adenosine pharmacologic stress testing in patients with first-degree atrioventricular block in the presence and absence of atrioventricular blocking medications.
MedLine Citation:
PMID:  10548144     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Pharmacologic stress testing in conjunction with radionuclide myocardial perfusion imaging may be used in the diagnosis of coronary artery disease and risk assessment. Adenosine can cause atrioventricular nodal (AV) block during infusion. In this study, we evaluated whether patients with baseline first-degree AV block could safely undergo adenosine stress testing. METHODS AND RESULTS: We evaluated the frequency of second- and third-degree AV block in patients with baseline first-degree AV block during adenosine stress testing, in the presence and absence of AV blocking medications (digitalis, beta-blockers, diltiazem, verapamil). Six hundred consecutive patients underwent pharmacologic stress myocardial perfusion imaging with adenosine infusion at 140 microg/kg/min for 6 minutes. A total of 43 patients (7.16%) had baseline first-degree AV block (PR interval > 200 msec), and 557 patients had a baseline PR interval < 200 msec. Twenty-one of the 43 patients (48.8 %) had further prolongation of PR interval > 240 msec, compared with 58 of 557 patients (10.4%) in the control group (P < .0001). In 16 of the 43 patients (37.3 %), second-degree AV block developed, compared with 45 of 557 patients (8.0 %) in the control group (P < .0001). In 6 of the 43 patients (13.9%), third-degree AV block developed, compared with 6 of 557 patients (1.0%) in the control group (P < .0001). All types of AV block were short duration and were not associated with any specific symptoms. None of these episodes required specific treatment. The presence of AV blocking medications (digitalis, beta-blockers, diltiazem, verapamil) did not increase the incidence of AV block during adenosine infusion. CONCLUSION: In patients with baseline PR interval of more than 200 msec, the frequency of second- and third-degree AV block during adenosine stress testing was significantly higher than in patients with a normal baseline PR interval. AV blocking medications did not increase the incidence of second- and third-degree AV block during adenosine stress testing. We conclude that it is safe to perform adenosine pharmacologic stress testing in patients with baseline PR prolongation.
Authors:
G S Alkoutami; W C Reeves; A Movahed
Related Documents :
2423334 - Ambulatory 24-hour continuous electrocardiographic monitoring in 54 patients with ankyl...
22960874 - Restless legs syndrome in iranian patients with multiple sclerosis.
20735714 - Sleep disordered breathing and arrhythmia burden in pacemaker recipients.
16449504 - Atrioventricular block after transcatheter closure of perimembranous ventricular septal...
10520794 - Long-term outcome of patients with unexplained syncope treated with an electrophysiolog...
15607364 - Bone marrow cd34+ cell count is predictive for adequate peripheral progenitor cell coll...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology     Volume:  6     ISSN:  1071-3581     ISO Abbreviation:  J Nucl Cardiol     Publication Date:    1999 Sep-Oct
Date Detail:
Created Date:  1999-11-24     Completed Date:  1999-11-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9423534     Medline TA:  J Nucl Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  495-7     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, East Carolina University School of Medicine, Greenville, North Carolina 27858, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine / adverse effects,  diagnostic use*
Adult
Aged
Aged, 80 and over
Coronary Circulation* / drug effects
Female
Heart Block / chemically induced,  drug therapy,  radionuclide imaging*
Humans
Male
Middle Aged
Retrospective Studies
Vasodilator Agents / adverse effects,  diagnostic use*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myocardial blood flow at rest and contractile reserve in patients with chronic coronary artery disea...
Next Document:  Automatic quantification of left ventricular ejection fraction from gated blood pool SPECT.